Почетна › Мозочни тумори › Тексас › Houston
Клинички испитувања за Мозочни тумори во Houston, TX
35 студии за Мозочни тумори бараат учесници на локации во и околу Houston (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Се регрутираФаза 1
- Baylor St. Luke's Medical Center, Houston
Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
Се регрутираФаза 2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
Се регрутираФаза 2
- M D Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Се регрутираФаза 1/2
- MD Anderson Cancer Center, Houston
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Се регрутираФаза 2
- Local Institution - 0085, Houston
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Се регрутираФаза 2
- Texas Children's Hospital, Houston
OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
Се регрутираФаза 1
- MD Anderson Cancer Center, Houston
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Се регрутираНабљудувачка студија
- M D Anderson Cancer Center, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Се регрутираФаза 1
- MD Anderson Cancer Center - University of Texas, Houston
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
Се регрутираНабљудувачка студија
- MD Anderson Cancer Center, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Се регрутираФаза 1/2
- University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Се регрутираНабљудувачка студија
- Texas Children's Hospital, Houston
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Се регрутираФаза 2
- UT MD Anderson Cancer Center, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Се регрутираФаза 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Се регрутираФаза 2
- Texas Children's Hospital, Houston
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Се регрутираФаза 2
- MD Anderson Cancer Center, Houston
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
Се регрутираФаза 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Се регрутираФаза 2
- Houston Methodist Neal Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Се регрутираФаза 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Се регрутираФаза 1
- Texas Children's Hospital, Houston
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Се регрутираНабљудувачка студија
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
Се регрутираФаза 1
- M D Anderson Cancer Center, Houston
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
Се регрутираФаза 2
- M D Anderson Cancer Center, Houston
Mapping of Human Cognition
Се регрутира
- The University of Texas Health Science Center at Houston, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Се регрутираФаза 2
- Texas Children's Hospital, Houston
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Се регрутира
- M D Anderson Cancer Center, Houston
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
Се регрутираНабљудувачка студија
- M D Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Се регрутираФаза 2
- M D Anderson Cancer Center, Houston
EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
Се регрутираФаза 2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Се регрутираФаза 1/2
- MD Anderson Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Се регрутираНабљудувачка студија
- Md Anderson Cancer Center, Houston
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
Се регрутираФаза 2
- M D Anderson Cancer Center, Houston
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
Се регрутира
- MD Anderson Cancer Center, Houston
Systematic Light Exposure in Pediatric Brain Tumor Survivors
Се регрутира
- Texas Children's Hospital, Houston
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
Се регрутираФаза 1/2
- MD Anderson, Houston
Испитувања за Мозочни тумори во други градови
- Boston, MA28 студии
- New York City, NY25 студии
- Washington, DC20 студии
- Los Angeles, CA16 студии
- Miami, FL15 студии
- Durham, NC14 студии
- St. Louis, MO12 студии
- Cleveland, OH11 студии
- Seattle, WA11 студии
- Rochester, MN11 студии
- Baltimore, MD11 студии
- Columbus, OH11 студии
Други студии во Houston
- Рак на бели дробови со не-мали клетки145 студии
- Рак на дојка126 студии
- Рак (сите типови)121 студија
- Метастатски карцином104 студии
- Колоректален карцином102 студии
- Карцином на јајниците89 студии
- Акутна миелоидна леукемија85 студии
- Рак на бели дробови78 студии
- Рак на простата76 студии
- Рак на ендометриумот68 студии
- Карцином на панкреасот61 студија
- Меланом59 студии
Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.